Company Filing History:
Years Active: 1998-2003
Title: The Innovative Contributions of Daniela Acerbi
Introduction
Daniela Acerbi is a prominent inventor based in Parma, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of effervescent formulations. With a total of 3 patents to her name, her work has garnered attention for its innovative approach to drug delivery.
Latest Patents
Acerbi's latest patents include groundbreaking pharmaceutical compositions that utilize an effervescent acid-base couple. One of her notable inventions is a pharmaceutical formulation in the form of a fast-dissolving tablet. This formulation comprises an active ingredient, sodium glycine carbonate, and an acid that reacts rapidly with it to release carbon dioxide. Another patent focuses on effervescent tablets that contain an active ingredient and an effervescent blend, which includes an acidic component and sodium glycine carbonate. The preferred acid components for these tablets are fumaric acid, maleic acid, and their salts. These tablets are prepared under normal thermo-hygrometric conditions using standard tableting equipment.
Career Highlights
Daniela Acerbi has established herself as a key figure in the pharmaceutical industry. Her work at Chiesi Farmaceutici S.p.a. has allowed her to explore innovative solutions in drug formulation. Her expertise in creating effective pharmaceutical compositions has positioned her as a valuable asset to her company and the industry at large.
Collaborations
Throughout her career, Acerbi has collaborated with notable colleagues, including Paolo Chiesi and Paolo Ventura. These partnerships have facilitated the exchange of ideas and have contributed to the advancement of her research and inventions.
Conclusion
In summary, Daniela Acerbi's contributions to pharmaceutical innovations are noteworthy. Her patents reflect her commitment to improving drug delivery systems, and her collaborations further enhance her impact in the field. Her work continues to inspire advancements in pharmaceutical formulations.